APA (7th ed.) Citation

Bakogeorgou, S., Filippatos, C., Malandrakis, P., Tentolouris, A., Terpos, E., Gavriatopoulou, M., & Ntanasis-Stathopoulos, I. (2025). Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from Clinical Trials. Cancers, 17(17), 2727. https://doi.org/10.3390/cancers17172727

Chicago Style (17th ed.) Citation

Bakogeorgou, Sabrina, Charalampos Filippatos, Panagiotis Malandrakis, Anastasios Tentolouris, Evangelos Terpos, Maria Gavriatopoulou, and Ioannis Ntanasis-Stathopoulos. "Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from Clinical Trials." Cancers 17, no. 17 (2025): 2727. https://doi.org/10.3390/cancers17172727.

MLA (9th ed.) Citation

Bakogeorgou, Sabrina, et al. "Safety and Efficacy of Bispecific Antibody Treatment in Relapsed/Refractory Multiple Myeloma: A Systematic Review and Meta-Analysis of Proportions from Clinical Trials." Cancers, vol. 17, no. 17, 2025, p. 2727, https://doi.org/10.3390/cancers17172727.